Results 61 to 70 of about 19,830 (241)

Prognostic Value of CEA, CA19-9, CA125, CA724, and CA242 in Serum and Ascites in Pseudomyxoma Peritonei

open access: yesFrontiers in Oncology, 2021
Purpose To investigate the expression of carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), CA19-9, CA724, and CA242 in serum and ascites of pseudomyxoma peritonei (PMP) patients and evaluate the predictive value of these elevated biomarkers in ...
Lei Liang   +7 more
semanticscholar   +1 more source

Computed tomography findings of peritoneal tumour in the absence of primary lesions: preliminary study

open access: yesAustralian Veterinary Journal, EarlyView.
Primary peritoneal tumours are uncommon and include mesothelioma and carcinoma. Mesothelioma identification is challenging, as there are no established rapid diagnostic methods. In the absence of a simple means of diagnosis, evaluation often requires several invasive biopsies, highlighting the need to develop a definitive diagnostic method.
T Tanaka, M Tomihari, T Hasegawa
wiley   +1 more source

Tailgut Cyst, an Unusual Cause of Pseudomyxoma Peritonei [PDF]

open access: yes, 2009
Background Retrorectal hamartoma, also known as tailgut cyst, is a rare tumor that arises from remnants of the embryonic postanal gut. The tumor occurs in the retrorectal space and may undergo malignant degeneration. Methods The clinical information on a
Luis Zappa   +2 more
core   +1 more source

Incidental Diagnosis of Pseudomyxoma Peritonei: A Case Report

open access: yesCureus, 2022
Pseudomyxoma peritonei (PMP) is a rare clinical condition characterized by disseminating gelatinous ascites within the peritoneal cavity with mucinous implants on peritoneal surfaces.
G. Sarpietro   +4 more
semanticscholar   +1 more source

Bicytopenia as a paraneoplastic syndrome for pseudomyxoma peritonei. Hematologic manifestations of a subtle disease [PDF]

open access: yes, 2015
Ciprian Tomuleasa,1,2 Bobe Petrushev,2 Madalina Vedean,2 Alexandru Irimie,2,3 Florin Zaharie,2 Ana-Maria Rosu,1 Delia Dima,1 Andrei Cucuianu1,2 1Department of Hematology, Ion Chiricuta Oncology Institute, 2Iuliu Hatieganu University of Medicine and ...
Tomuleasa C   +7 more
core  

Appendix Mucinous Neoplasm

open access: yesClinical Case Reports, Volume 14, Issue 7, July 2026.
ABSTRACT A 36‐year‐old female patient accepted the laparoscopic appendectomy; she was diagnosed with low‐grade appendiceal mucinous neoplasm. There are no signs of recurrence after 4 years of follow‐up. We review and discuss the advanced literature on LAMN diagnosis and surgical treatment principles.
Ping Xiao, Tao Xu, Ming Zhou, ZhenYu Lei
wiley   +1 more source

Management of Mucinous Urachal Neoplasm Presenting as Pseudomyxoma Peritonei [PDF]

open access: yes, 2008
Background Mucinous neoplasms of the urachus are rare malignancies so that the physicians’ index of suspicion for a timely and accurate diagnosis is low. Also, this disease may present with a wide variety of symptoms and signs.
Paul H Sugarbaker   +3 more
core   +1 more source

Pseudomyxoma Peritonei: A Challenging Clinical Diagnosis. Case Report and Review of the Literature.

open access: yesCancer Diagnosis & Prognosis
Background Pseudomyxoma peritonei (PMP) is a clinical entity of subtle onset abdominal pain, ascites, and distention associated with characteristic imaging.
N. Tsoukalas   +10 more
semanticscholar   +1 more source

Clinical significance of laparoscopic cytoreductive surgery for appendiceal pseudomyxoma peritonei with limited disease and low tumor burden.

open access: yesAsian Journal of Surgery, 2022
OBJECTIVE To investigate the clinical value of laparoscopic cytoreductive surgery (CRS) in treating of appendiceal pseudomyxoma peritonei with limited disease and low tumor burden.
Chong Wang   +9 more
semanticscholar   +1 more source

Pseudomyxoma peritonei

open access: yesMedicina Clínica, 2023
Nathaniel Juárez de la Garza   +3 more
  +7 more sources

Home - About - Disclaimer - Privacy